| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | LAQ824 |
|---|
| Description | Purity >95%. LAQ824 is a hydroxamate-based inhibitor of histone deacetylases (HDACs) with an IC50 value of 30 nM. It inhibits the growth of colon, breast, prostate, and non-small cell lung cancer cell lines at concentrations of less than 1 μM. LAQ824 augments the actions of fludarabine and imatinib mesylate in human leukemia cells. Through its effects on HDACs, LAQ824 induces acetylation of histones, Alpha-tubulin, and heat shock protein 90 (Hsp90). Acetylation of Hsp90 blocks its chaperone function, resulting in changes in levels of several client proteins, including estrogen receptor-Alpha, Hsp72, and Raf-1. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide, Dacinostat, NVP-LAQ824 |
|---|
| Gene, Accession, CAS # | CAS: 404951-53-7 |
|---|
| Catalog # | LS-H8412 |
|---|
| Price | |
|---|
| Order / More Info | LAQ824 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|